Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-05-28

Clinical Trial Update: Pharmacokinetics of Imrecoxib in Subjects With Hepatic Insufficiency [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating Imrecoxib in subjects with hepatic insufficiency, in knee osteoarthritis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Imrecoxib (Imrecoxib)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Knee Osteoarthritis | Phase 1 | Status: UNKNOWN